Report cover image

Vaccine Technologies Global Market Report 2025

Published Jul 07, 2025
Length 175 Pages
SKU # BRC20166244

Description

Vaccine Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vaccine technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for vaccine technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vaccine technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Recombinant Or Conjugate Or Subunit; Inactivated; Live Attenuated; Toxoid

2) By Route Of Administration: Parenteral; Oral; Nasal

3) By Disease Indication: Infectious Diseases; Non-Infectious Diseases

4) By Age Group: Pediatric; Adults

5) By Distribution Channel: Hospital And Retail Pharmacies; Government Suppliers; Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines; Virus-Like Particle (VLP) Vaccines; Glycoconjugate Vaccines; Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines; Split-Virus Inactivated Vaccines; Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines; Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines; Tetanus Toxoid Vaccines

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc; Sanofi S.A.; AstraZeneca plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Vaccine Technologies Market Characteristics
3. Vaccine Technologies Market Trends And Strategies
4. Vaccine Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Vaccine Technologies Growth Analysis And Strategic Analysis Framework
5.1. Global Vaccine Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vaccine Technologies Market Growth Rate Analysis
5.4. Global Vaccine Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vaccine Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vaccine Technologies Total Addressable Market (TAM)
6. Vaccine Technologies Market Segmentation
6.1. Global Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Or Conjugate Or Subunit
Inactivated
Live Attenuated
Toxoid
6.2. Global Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
Nasal
6.3. Global Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Non-Infectious Diseases
6.4. Global Vaccine Technologies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adults
6.5. Global Vaccine Technologies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital And Retail Pharmacies
Government Suppliers
Other Distribution Channels
6.6. Global Vaccine Technologies Market, Sub-Segmentation Of Recombinant Or Conjugate Or Subunit, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Subunit Vaccines
Virus-Like Particle (VLP) Vaccines
Glycoconjugate Vaccines
Recombinant Vector Vaccines
6.7. Global Vaccine Technologies Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole-Virus Inactivated Vaccines
Split-Virus Inactivated Vaccines
Purified Inactivated Vaccines
6.8. Global Vaccine Technologies Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Live Attenuated Vaccines
Bacterial Live Attenuated Vaccines
6.9. Global Vaccine Technologies Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diphtheria Toxoid Vaccines
Tetanus Toxoid Vaccines
7. Vaccine Technologies Market Regional And Country Analysis
7.1. Global Vaccine Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vaccine Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Vaccine Technologies Market
8.1. Asia-Pacific Vaccine Technologies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Vaccine Technologies Market
9.1. China Vaccine Technologies Market Overview
9.2. China Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Vaccine Technologies Market
10.1. India Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Vaccine Technologies Market
11.1. Japan Vaccine Technologies Market Overview
11.2. Japan Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Vaccine Technologies Market
12.1. Australia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Vaccine Technologies Market
13.1. Indonesia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Vaccine Technologies Market
14.1. South Korea Vaccine Technologies Market Overview
14.2. South Korea Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Vaccine Technologies Market
15.1. Western Europe Vaccine Technologies Market Overview
15.2. Western Europe Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Vaccine Technologies Market
16.1. UK Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Vaccine Technologies Market
17.1. Germany Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Vaccine Technologies Market
18.1. France Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Vaccine Technologies Market
19.1. Italy Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Vaccine Technologies Market
20.1. Spain Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Vaccine Technologies Market
21.1. Eastern Europe Vaccine Technologies Market Overview
21.2. Eastern Europe Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Vaccine Technologies Market
22.1. Russia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Vaccine Technologies Market
23.1. North America Vaccine Technologies Market Overview
23.2. North America Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Vaccine Technologies Market
24.1. USA Vaccine Technologies Market Overview
24.2. USA Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Vaccine Technologies Market
25.1. Canada Vaccine Technologies Market Overview
25.2. Canada Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Vaccine Technologies Market
26.1. South America Vaccine Technologies Market Overview
26.2. South America Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Vaccine Technologies Market
27.1. Brazil Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Vaccine Technologies Market
28.1. Middle East Vaccine Technologies Market Overview
28.2. Middle East Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Vaccine Technologies Market
29.1. Africa Vaccine Technologies Market Overview
29.2. Africa Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Vaccine Technologies Market Competitive Landscape And Company Profiles
30.1. Vaccine Technologies Market Competitive Landscape
30.2. Vaccine Technologies Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Vaccine Technologies Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. GSK plc
31.3. Moderna Inc.
31.4. CSL Limited
31.5. Bharat Biotech International Limited
31.6. Bavarian Nordic A/S
31.7. Takeda Pharmaceutical Company Limited
31.8. Sinovac Biotech Ltd.
31.9. Emergent BioSolutions Inc.
31.10. Valneva SE
31.11. Novavax Inc.
31.12. Dynavax Technologies Corporation
31.13. CureVac N.V.
31.14. Inovio Pharmaceuticals Inc
31.15. Mitsubishi Tanabe Pharma Corporation
32. Global Vaccine Technologies Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Vaccine Technologies Market
34. Recent Developments In The Vaccine Technologies Market
35. Vaccine Technologies Market High Potential Countries, Segments and Strategies
35.1 Vaccine Technologies Market In 2029 - Countries Offering Most New Opportunities
35.2 Vaccine Technologies Market In 2029 - Segments Offering Most New Opportunities
35.3 Vaccine Technologies Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.